Editas Medicine Beats Expectations in Q3

Editas Medicine Surprises with Better-Than-Expected Q3 Results: Despite Reporting a Loss, Company Beats Wall Street Forecasts in Both Loss per Share and Revenue.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.